Save your place

Sign in to WhoBought

Please try again later.

EyePoint Pharmaceuticals, Inc. (EYPT) institutional ownership

Latest close $12.66 Jul 22, 2026
Market cap$668M 52-week range SectorHealthcare
Funds holding · Q1 2026
174
reported EYPT position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
112 buyers · 62 sellers

EyePoint Pharmaceuticals, Inc. (EYPT) price and institutional activity

Dates

Q1 2026

$0 bought by 112 investors
Commodore Capital LPCitadel Advisors LLC +110 more
$0 sold by 62 investors
Tcg Crossover Management, LLCAdage Capital Partners Gp, L.L.C. +60 more
Bought Sold Totals per quarter; hover a bar for the names.

EyePoint Pharmaceuticals, Inc. (EYPT) institutional activity · 174

Investor Type Est. change Change Δ Own Date
Tcg Crossover Management, LLC · Exited
Change −3.6M Δ Own −100.0% Date Q1 2026
Tcg Crossover Management, LLC Exited· Q1 2026 −3.6M −100.0% Q1 2026
Commodore Capital LP · New
Change +2.8M Date Q1 2026
Commodore Capital LP New· Q1 2026 +2.8M Q1 2026
Citadel Advisors LLC New· Q1 2026 +1.9M Q1 2026
Adage Capital Partners Gp, L.L.C. · Reduced
Change −1.4M Date Q1 2026
Adage Capital Partners Gp, L.L.C. Reduced· Q1 2026 −1.4M Q1 2026
Orbimed Advisors LLC · Reduced
Change −1.4M Date Q1 2026
Orbimed Advisors LLC Reduced· Q1 2026 −1.4M Q1 2026
Eventide Asset Management, LLC · New
Change +1.2M Date Q1 2026
Eventide Asset Management, LLC New· Q1 2026 +1.2M Q1 2026
Spruce Street Capital LP · Exited
Change −982K Δ Own −100.0% Date Q1 2026
Spruce Street Capital LP Exited· Q1 2026 −982K −100.0% Q1 2026
Morgan Stanley · Added
Change +872K Date Q1 2026
Morgan Stanley Added· Q1 2026 +872K Q1 2026
Balyasny Asset Management L.P. · Added
Change +843K Date Q1 2026
Balyasny Asset Management L.P. Added· Q1 2026 +843K Q1 2026
HSBC Holdings PLC · New
Change +833K Date Q1 2026
HSBC Holdings PLC New· Q1 2026 +833K Q1 2026
Sio Capital Management, LLC · New
Change +722K Date Q1 2026
Sio Capital Management, LLC New· Q1 2026 +722K Q1 2026
Janus Henderson Group PLC · Added
Change +663K Date Q1 2026
Janus Henderson Group PLC Added· Q1 2026 +663K Q1 2026
Goldman Sachs Group Inc · Reduced
Change −550K Date Q1 2026
Goldman Sachs Group Inc Reduced· Q1 2026 −550K Q1 2026
Paradigm Biocapital Advisors LP · Reduced
Change −549K Date Q1 2026
Paradigm Biocapital Advisors LP Reduced· Q1 2026 −549K Q1 2026
Blue Owl Capital Holdings LP · Added
Change +520K Date Q1 2026
Blue Owl Capital Holdings LP Added· Q1 2026 +520K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 174

Famous investor activity in EyePoint Pharmaceuticals, Inc. (EYPT)

EyePoint Pharmaceuticals, Inc. (EYPT) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Duker Jay S. · Director 2 operations 0
Owned 0 Trade date Jul 10, 2026 Filed date Jul 14, 2026
Duker Jay S. Director 2 operations 0 0 Jul 10, 2026 Jul 14, 2026
Duker Jay S. · Director Tax withholding or exercise payment (F) -$119K
Price $14.72 Qty -8K Owned 10K ΔOwn −45.7% Trade date Jul 10, 2026 Filed date Jul 14, 2026
Duker Jay S. Director Tax withholding or exercise payment (F) $14.72 -8K -$119K 10K −45.7% Jul 10, 2026 Jul 14, 2026
Ribeiro Ramiro · Officer 2 operations −$73K
Price $15.00–$15.02 Qty −5K Owned 0 ΔOwn −100.0% Trade date Jun 30, 2026 Filed date Jul 2, 2026
Ribeiro Ramiro Officer 2 operations $15.00–$15.02 −5K −$73K 0 −100.0% Jun 30, 2026 Jul 2, 2026
Ribeiro Ramiro · Officer 4 operations 0
Price $8.26 Owned 76K Trade date Jun 30, 2026 Filed date Jul 2, 2026
Ribeiro Ramiro Officer 4 operations $8.26 0 76K Jun 30, 2026 Jul 2, 2026
Elston George · CFO 2 operations 0
Owned 0 Trade date May 25, 2026 Filed date May 27, 2026
Elston George CFO 2 operations 0 0 May 25, 2026 May 27, 2026
Elston George · CFO Tax withholding or exercise payment (F) -$47K
Price $12.93 Qty -4K Owned 92K Trade date May 25, 2026 Filed date May 27, 2026
Elston George CFO Tax withholding or exercise payment (F) $12.93 -4K -$47K 92K May 25, 2026 May 27, 2026
Ribeiro Ramiro · Officer Sell −$37K
Price $15.00 Qty −2K Owned 0 Trade date Apr 17, 2026 Filed date Apr 20, 2026
Ribeiro Ramiro Officer Sell $15.00 −2K −$37K 0 Apr 17, 2026 Apr 20, 2026
Ribeiro Ramiro · Officer 2 operations 0
Price $8.26 Owned 80K Trade date Apr 17, 2026 Filed date Apr 20, 2026
Ribeiro Ramiro Officer 2 operations $8.26 0 80K Apr 17, 2026 Apr 20, 2026
Duker Jay S. · Director, Officer 6 operations $0
Price $8.75–$13.11 Qty 0 Owned 8K Trade date Mar 23, 2026 Filed date Mar 24, 2026
Duker Jay S. Director, Officer 6 operations $8.75–$13.11 0 $0 8K Mar 23, 2026 Mar 24, 2026
Duker Jay S. · Director, Officer Buy +$20K
Price $13.15 Qty +2K Owned 101K Trade date Mar 16, 2026 Filed date Mar 16, 2026
Duker Jay S. Director, Officer Buy $13.15 +2K +$20K 101K Mar 16, 2026 Mar 16, 2026
Ribeiro Ramiro · Officer Sell −$44K
Price $17.87 Qty −2K Owned 0 Trade date Mar 4, 2026 Filed date Mar 5, 2026
Ribeiro Ramiro Officer Sell $17.87 −2K −$44K 0 Mar 4, 2026 Mar 5, 2026
Ribeiro Ramiro · Officer 2 operations 0
Price $8.26 Owned 83K Trade date Mar 4, 2026 Filed date Mar 5, 2026
Ribeiro Ramiro Officer 2 operations $8.26 0 83K Mar 4, 2026 Mar 5, 2026
Elston George · Officer 2 operations 0
Owned 88K Trade date Mar 2, 2026 Filed date Mar 6, 2026
Elston George Officer 2 operations 0 88K Mar 2, 2026 Mar 6, 2026
Ribeiro Ramiro · Officer Sell −$37K
Price $15.00 Qty −2K Owned 0 Trade date Feb 17, 2026 Filed date Feb 18, 2026
Ribeiro Ramiro Officer Sell $15.00 −2K −$37K 0 Feb 17, 2026 Feb 18, 2026
Ribeiro Ramiro · Officer 2 operations 0
Price $8.26 Owned 85K Trade date Feb 17, 2026 Filed date Feb 18, 2026
Ribeiro Ramiro Officer 2 operations $8.26 0 85K Feb 17, 2026 Feb 18, 2026
15 of 51
15 of 51 Sign in to continue to older insider transactions.

EyePoint Pharmaceuticals, Inc. (EYPT) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Cormorant Asset Management, LP
% of shares outstanding 12.2% Filing date Nov 14, 2024
Cormorant Asset Management, LP 12.2% Nov 14, 2024
Suvretta Capital Management, LLC 4.8M
% of shares outstanding 10.0% Filing date Feb 13, 2024
Suvretta Capital Management, LLC 4.8M 10.0% Feb 13, 2024
Franklin Resources Inc 4.6M
% of shares outstanding 9.5% Filing date Feb 6, 2024
Franklin Resources Inc 4.6M 9.5% Feb 6, 2024
Cormorant Global Healthcare Master Fund, LP 3.2M
% of shares outstanding 9.3% Filing date May 1, 2023
Cormorant Global Healthcare Master Fund, LP 3.2M 9.3% May 1, 2023
Adage Capital Partners Gp, L.L.C. 4.5M
% of shares outstanding 9.2% Filing date Feb 7, 2024
Adage Capital Partners Gp, L.L.C. 4.5M 9.2% Feb 7, 2024
Blackrock, Inc. 4.2M
% of shares outstanding 7.8% Filing date Nov 8, 2024
Blackrock, Inc. 4.2M 7.8% Nov 8, 2024
Ra Capital Management, L.P. 3.1M
% of shares outstanding 6.1% Filing date Feb 14, 2024
Ra Capital Management, L.P. 3.1M 6.1% Feb 14, 2024
Vanguard Group Inc 3.0M
% of shares outstanding 5.7% Filing date Nov 12, 2024
Vanguard Group Inc 3.0M 5.7% Nov 12, 2024
8 of 15

EyePoint Pharmaceuticals, Inc. (EYPT) ownership FAQ

Who owns EYPT?

174 reporting institutions disclosed EYPT position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.